Optipharm.CO.,LTD (KOSDAQ:153710)
South Korea · Delayed Price · Currency is KRW 5,000.00
+60.00 (1.21%)
At close: Jan 23, 2026
Optipharm.CO.,LTD Revenue
Optipharm.CO.,LTD had revenue of 5.68B KRW in the quarter ending September 30, 2025, with 18.61% growth. This brings the company's revenue in the last twelve months to 21.98B, up 15.17% year-over-year. In the year 2024, Optipharm.CO.,LTD had annual revenue of 19.64B with 13.03% growth.
Revenue (ttm)
21.98B
Revenue Growth
+15.17%
P/S Ratio
3.34
Revenue / Employee
n/a
Employees
n/a
Market Cap
73.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.64B | 2.26B | 13.03% |
| Dec 31, 2023 | 17.37B | 1.36B | 8.52% |
| Dec 31, 2022 | 16.01B | 1.75B | 12.27% |
| Dec 31, 2021 | 14.26B | 1.21B | 9.29% |
| Dec 31, 2020 | 13.05B | -606.93M | -4.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ahn-Gook Pharmaceutical | 300.96B |
| Cosmax Nbt | 293.75B |
| Korea Arlico Pharm | 205.21B |
| Daehan Nupharm | 201.59B |
| Jin Yang Pharmaceutical | 117.19B |
| Sinsin Pharmaceutical | 110.29B |
| Hwail Pharmaceutical | 107.87B |
| Sinil Pharmaceutical | 80.97B |